Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU

NCT05511129 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.

NCT NCT05511129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05511129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU
Lead sponsor
Fondation Hôpital Saint-Joseph
Phase
Observational
Overall status
Unknown status
Start date
May 12, 2022
Completion date
June 30, 2023
Enrollment
1,053 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, nosocomial infection